CXCR4 and Right ventricular hypertrophy: As shown in the results, two weeks of treatment with the CXCR4 inhibitor significantly decreased hypoxia-induced pulmonary pressure, right ventricular hypertrophy and vascular remodeling of pulmonary arteries in rats.